Skin Lightening Cosmetic Raw Powder CAS 123-99-9 99% Pure Azelaic Acid Powder

• Type: Skin Care
• Function: Whitening/Lightening, Acne Treatment, Nourishing
• Main Ingredient: Azelaic Acid
• Group: Adults
• Certification: ISO
• Quality Guarantee Period: Two Years
• Store Method: Place the Shade
• Cosmetics Approval No.: -
• Grade: Cosmetic Grade, Medicine Grade
• CAS No.: 123-99-9
• Supplier: Greenway
• Appearance: White Powder
• Sample: Sample
• MOQ: 1kg
• Application: Cosmetic Grade, Medicine Grade
• Mf: C9h16o4
• Einecs: 204-669-1
• Transport Package: Paper Bag or Drum.
• Specification: 1kg/bag; 25kg/drum
• Trademark: Greenway Biotech
• Origin: China
• HS Code: 2942000000
• Production Capacity: 100kg/Year

Product Description

Skin Lightening Cosmetic Raw Powder CAS 123-99-9 99% Pure Azelaic Acid Powder

Product Name	Azelaic Acid Powder
Purity	99%
MF	C9H16O4
Appearance	White Powder
Test Method	HPLC

Description:

     Azelaic acid powder is an organic compound with the formula (CH2)7(CO2H)2. This
saturated dicarboxylic acid exists as a white powder. It is found in wheat, rye, and barley.
It is a component of a number of hair and skin conditioners.


Application:

1.Used as a good skin permeability. Cream cosmetics adding azelaic acid can increase
absorption through the skin functions, and a brightening of the effectiveness of Lipstick. 
2.Azelaic acid can inhibit microbial protein synthesis, can be used as anti-acne drug. 
3.Azelaic acid or zinc salts, and vitamin B6 compatibility, can be used for hair care products
for men, hair loss
disease etc.

Function:
1.The product used in combination with other anti-TB drugs initial treatment and
retreatment of various tuberculosis, including tuberculous meningitis treatment.

2.The product used in combination with other drugs leprosy, non-tuberculous mycobacterial
infections.

3.The goods and vancomycin (intravenous) can be combined for methicillin resistant
Staphylococcus aureus caused serious infections. Rifampicin and erythromycin joint
programs can be used to Legionella serious infections.

4. For asymptomatic carriers of Neisseria meningitidis to eliminate Neisseria meningitidis
nasopharynx; but not for Neisseria meningitidis infection.